Noumi Limited (ASX:NOU)

G1 Therapeutics Revenue

Noumi had revenue of 299.29M AUD in the half year ending December 31, 2024, with 6.96% growth. This brings the company's revenue in the last twelve months to 592.40M, up 4.22% year-over-year. In the fiscal year ending June 30, 2024, Noumi had annual revenue of 589.79M with 6.93% growth.

• Revenue (ttm): 592.40M
• Revenue Growth: +4.22%
• P/S Ratio: 0.07
• Revenue / Employee: 1.18M
• Employees: 500
• Market Cap: 42.95M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2024	589.79M	38.23M	6.93%
Jun 30, 2023	551.56M	29.22M	5.59%
Jun 30, 2022	522.34M	-24.95M	-4.56%
Jun 30, 2021	547.29M	30.64M	5.93%
Jun 30, 2020	516.65M	54.88M	11.89%